Skip to main content
. 2021 Sep 12;5(6):e12582. doi: 10.1002/rth2.12582

FIGURE 3.

FIGURE 3

Analysis of plasma Angiopoietin‐2 (Ang2) and syndecan‐1 levels in patients receiving hemodialysis with coronavirus disease 2019 (COVID‐19). Plasma levels of Ang2 and syndecan‐1 were determined by ELISA. (A) No significant difference in Ang2 levels were observed between the patient groups. (B) Syndecan‐1 levels were significantly higher in patients with severe COVID compared to controls and mild cases. (*<.05, **<.005. One‐way ANOVA, Tukey’s multiple comparisons). Purple symbols represent patients who died